Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Baxter
QuintilesIMS
Daiichi Sankyo
Chinese Patent Office
Merck
McKinsey
Farmers Insurance

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022152

« Back to Dashboard

NDA 022152 describes STAVZOR, which is a drug marketed by Bionpharma Inc and is included in one NDA. Additional details are available on the STAVZOR profile page.

The generic ingredient in STAVZOR is valproic acid. There are seventeen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the valproic acid profile page.
Summary for 022152
Tradename:STAVZOR
Applicant:Bionpharma Inc
Ingredient:valproic acid
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 022152

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED RELEASE;ORALStrength125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 29, 2008TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED RELEASE;ORALStrength250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 29, 2008TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED RELEASE;ORALStrength500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 29, 2008TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Fuji
Baxter
Cantor Fitzgerald
Cerilliant
Daiichi Sankyo
Healthtrust
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.